Takayasu's arteritis mimicking Kawasaki disease in 7-month-old infant, successfully treated with glucocorticosteroids and intravenous immunoglobulins
- PMID: 20473497
- DOI: 10.1007/s00296-010-1518-y
Takayasu's arteritis mimicking Kawasaki disease in 7-month-old infant, successfully treated with glucocorticosteroids and intravenous immunoglobulins
Abstract
Takayasu's arteritis (TA) rarely occurs in infants. There are only four reports on TA in children below 1 year of age, revealing diversity of its symptoms. We describe a 7-month-old female infant hospitalized for hectic fever, irritability, high acute phase indices, and coronary artery dilatations found on echocardiography, which suggested Kawasaki disease (KD). Despite of standard treatment, rapid development of thoracic and abdominal aorta aneurysms occurred, while coronary artery abnormalities regressed. The initial diagnosis was changed for TA. Subsequently implemented glucocorticosteroids led to clinical and laboratory normalization. However, 2 months after treatment discontinuation, TA relapsed. Glucocorticosteroid therapy was restarted with additional introduction of intravenous immunoglobulins (IVIG), resulting in full and stable remission lasting over 1 year. Thus, diagnosis and treatment of infant TA pose a big challenge to physicians. TA onset in infants may mimics KD. Prolonged glucocorticosteroids and IVIG administration can be recommended in the youngest patients with TA.
Similar articles
-
Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.Turk J Pediatr. 2019;61(5):648-656. doi: 10.24953/turkjped.2019.05.002. Turk J Pediatr. 2019. PMID: 32104995
-
Developments in large and midsize vasculitis.Rheum Dis Clin North Am. 2013 Nov;39(4):855-75. doi: 10.1016/j.rdc.2013.08.002. Rheum Dis Clin North Am. 2013. PMID: 24182858
-
Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.Lancet Child Adolesc Health. 2018 Dec;2(12):855-862. doi: 10.1016/S2352-4642(18)30293-1. Epub 2018 Oct 16. Lancet Child Adolesc Health. 2018. PMID: 30337183
-
Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.Clin Exp Rheumatol. 2012 Jan-Feb;30(1 Suppl 70):S114-29. Epub 2012 May 11. Clin Exp Rheumatol. 2012. PMID: 22640655 Review.
-
A meta-analysis of re-treatment for intravenous immunoglobulin-resistant Kawasaki disease.Cardiol Young. 2015 Aug;25(6):1182-90. doi: 10.1017/S1047951114002601. Epub 2015 Jan 19. Cardiol Young. 2015. PMID: 25597708 Review.
Cited by
-
Clinical observations on infliximab treatment of infantile onset Takayasu arteritis.Pediatr Rheumatol Online J. 2022 Aug 4;20(1):61. doi: 10.1186/s12969-022-00708-4. Pediatr Rheumatol Online J. 2022. PMID: 35927694 Free PMC article.
-
Coincidence of Takayasu Arteritis and Multiple Sclerosis: Narrative Review and Case Report.Biomed Hub. 2025 Mar 20;10(1):72-80. doi: 10.1159/000545237. eCollection 2025 Jan-Dec. Biomed Hub. 2025. PMID: 40290577 Free PMC article.
-
Overlap of Takayasu Arteritis and Kawasaki Disease in Infants.Chronic Dis Transl Med. 2025 Jan 27;11(2):156-160. doi: 10.1002/cdt3.157. eCollection 2025 Jun. Chronic Dis Transl Med. 2025. PMID: 40486957 Free PMC article.
-
Continuous infusion of lipo-prostaglandin E1 for Takayasu's arteritis with heart failure in an 11-month-old baby: a case report.J Med Case Rep. 2018 Sep 2;12(1):266. doi: 10.1186/s13256-018-1769-x. J Med Case Rep. 2018. PMID: 30172258 Free PMC article.
-
A retrospective study of infantile-onset Takayasu arteritis: experience from a tertiary referral center in China.Front Cardiovasc Med. 2024 Jan 31;11:1249305. doi: 10.3389/fcvm.2024.1249305. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38357518 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical